Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lot Quality Assurance Sampling | 8 | 2015 | 17 | 2.980 |
Why?
|
Disease Outbreaks | 13 | 2021 | 1771 | 1.570 |
Why?
|
Schistosoma mansoni | 3 | 2012 | 149 | 0.900 |
Why?
|
Schistosomiasis mansoni | 2 | 2012 | 85 | 0.820 |
Why?
|
Cluster Analysis | 8 | 2015 | 2715 | 0.700 |
Why?
|
Space-Time Clustering | 2 | 2009 | 49 | 0.670 |
Why?
|
Sentinel Surveillance | 3 | 2011 | 281 | 0.650 |
Why?
|
Program Evaluation | 5 | 2018 | 2488 | 0.640 |
Why?
|
Quality Assurance, Health Care | 5 | 2015 | 2212 | 0.640 |
Why?
|
Poliomyelitis | 2 | 2018 | 103 | 0.590 |
Why?
|
Population Surveillance | 6 | 2014 | 2616 | 0.590 |
Why?
|
Parasite Egg Count | 2 | 2012 | 27 | 0.560 |
Why?
|
Influenza, Human | 4 | 2013 | 1479 | 0.560 |
Why?
|
Basic Reproduction Number | 2 | 2021 | 31 | 0.550 |
Why?
|
Sampling Studies | 2 | 2015 | 623 | 0.540 |
Why?
|
Drug Resistance, Viral | 2 | 2013 | 820 | 0.510 |
Why?
|
Entropy | 1 | 2015 | 209 | 0.500 |
Why?
|
Bayes Theorem | 2 | 2013 | 2308 | 0.500 |
Why?
|
Data Interpretation, Statistical | 4 | 2013 | 2716 | 0.480 |
Why?
|
Mass Vaccination | 1 | 2014 | 105 | 0.420 |
Why?
|
HIV-1 | 4 | 2015 | 6939 | 0.420 |
Why?
|
Data Collection | 3 | 2014 | 3339 | 0.420 |
Why?
|
Tuberculosis, Pulmonary | 4 | 2016 | 810 | 0.410 |
Why?
|
Crime Victims | 1 | 2015 | 322 | 0.390 |
Why?
|
Health Surveys | 3 | 2015 | 4036 | 0.370 |
Why?
|
Computer Simulation | 9 | 2018 | 6194 | 0.350 |
Why?
|
Public Sector | 2 | 2012 | 265 | 0.350 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2012 | 459 | 0.340 |
Why?
|
Biostatistics | 1 | 2011 | 161 | 0.340 |
Why?
|
HIV Infections | 6 | 2015 | 16715 | 0.340 |
Why?
|
Tuberculosis, Multidrug-Resistant | 5 | 2016 | 912 | 0.330 |
Why?
|
Immunization | 1 | 2013 | 1256 | 0.320 |
Why?
|
Topography, Medical | 1 | 2007 | 37 | 0.310 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1364 | 0.310 |
Why?
|
Firearms | 1 | 2015 | 598 | 0.310 |
Why?
|
Disease Transmission, Infectious | 1 | 2013 | 547 | 0.310 |
Why?
|
Leukemia | 2 | 2014 | 1511 | 0.300 |
Why?
|
Research Design | 2 | 2021 | 5986 | 0.290 |
Why?
|
Health Care Surveys | 1 | 2014 | 2453 | 0.280 |
Why?
|
Sample Size | 3 | 2015 | 845 | 0.270 |
Why?
|
Health Status Indicators | 1 | 2011 | 970 | 0.260 |
Why?
|
HIV | 1 | 2012 | 1604 | 0.250 |
Why?
|
Epidemiologic Measurements | 1 | 2004 | 23 | 0.250 |
Why?
|
Prevalence | 10 | 2022 | 15221 | 0.250 |
Why?
|
Models, Statistical | 6 | 2015 | 5101 | 0.240 |
Why?
|
Drug Resistance, Bacterial | 1 | 2010 | 1035 | 0.220 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1956 | 0.210 |
Why?
|
Health Status | 1 | 2015 | 4033 | 0.210 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5321 | 0.200 |
Why?
|
DNA, Viral | 1 | 2007 | 2227 | 0.180 |
Why?
|
Anti-HIV Agents | 2 | 2013 | 4255 | 0.180 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2002 | 407 | 0.180 |
Why?
|
Humans | 52 | 2022 | 744376 | 0.180 |
Why?
|
Phylogeny | 1 | 2007 | 2804 | 0.170 |
Why?
|
Antitubercular Agents | 3 | 2016 | 1320 | 0.170 |
Why?
|
Infant, Premature, Diseases | 2 | 2002 | 707 | 0.170 |
Why?
|
Pandemics | 3 | 2020 | 8386 | 0.160 |
Why?
|
Statistics as Topic | 1 | 2005 | 2373 | 0.160 |
Why?
|
Infant, Extremely Low Birth Weight | 2 | 2009 | 89 | 0.160 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1939 | 0.160 |
Why?
|
Algorithms | 6 | 2015 | 13882 | 0.160 |
Why?
|
New York | 2 | 2014 | 886 | 0.150 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2002 | 482 | 0.150 |
Why?
|
Likelihood Functions | 2 | 2013 | 1005 | 0.150 |
Why?
|
Mass Screening | 1 | 2012 | 5255 | 0.140 |
Why?
|
Models, Genetic | 1 | 2007 | 3493 | 0.140 |
Why?
|
Environmental Exposure | 1 | 2011 | 4232 | 0.140 |
Why?
|
Chronic Disease | 2 | 2011 | 9145 | 0.140 |
Why?
|
Echoencephalography | 3 | 2008 | 135 | 0.140 |
Why?
|
Infection Control | 2 | 2015 | 965 | 0.140 |
Why?
|
Morbidity | 1 | 2021 | 1768 | 0.130 |
Why?
|
Ventilation | 1 | 2015 | 127 | 0.130 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14723 | 0.130 |
Why?
|
Rifampin | 1 | 2016 | 315 | 0.120 |
Why?
|
Geographic Information Systems | 2 | 2014 | 281 | 0.120 |
Why?
|
Prenatal Care | 1 | 2022 | 1092 | 0.120 |
Why?
|
Florida | 1 | 2015 | 435 | 0.120 |
Why?
|
Cerebral Palsy | 2 | 2009 | 459 | 0.120 |
Why?
|
Local Government | 1 | 2014 | 79 | 0.110 |
Why?
|
Disinfection | 1 | 2015 | 191 | 0.110 |
Why?
|
Residence Characteristics | 2 | 2015 | 2050 | 0.110 |
Why?
|
Africa, Eastern | 1 | 2012 | 71 | 0.110 |
Why?
|
Child Health Services | 1 | 2018 | 667 | 0.110 |
Why?
|
Measles Vaccine | 1 | 2013 | 76 | 0.110 |
Why?
|
Anthelmintics | 1 | 2012 | 62 | 0.110 |
Why?
|
United Nations | 1 | 2013 | 165 | 0.100 |
Why?
|
Regression Analysis | 2 | 2015 | 6459 | 0.100 |
Why?
|
Cerebral Hemorrhage | 2 | 2009 | 2647 | 0.100 |
Why?
|
South Africa | 2 | 2013 | 1731 | 0.100 |
Why?
|
Total Quality Management | 1 | 2012 | 274 | 0.100 |
Why?
|
Nigeria | 1 | 2014 | 733 | 0.100 |
Why?
|
Uganda | 1 | 2015 | 1237 | 0.100 |
Why?
|
Health Services Research | 1 | 2018 | 1836 | 0.100 |
Why?
|
Models, Theoretical | 2 | 2015 | 3589 | 0.100 |
Why?
|
Micronutrients | 1 | 2013 | 375 | 0.090 |
Why?
|
Mosquito Nets | 1 | 2010 | 5 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1060 | 0.090 |
Why?
|
Chemoprevention | 1 | 2012 | 319 | 0.090 |
Why?
|
Culex | 1 | 2009 | 19 | 0.090 |
Why?
|
Cost Control | 1 | 2012 | 624 | 0.090 |
Why?
|
Developmental Disabilities | 2 | 2009 | 1456 | 0.090 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1680 | 0.090 |
Why?
|
Masks | 1 | 2012 | 197 | 0.090 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2013 | 365 | 0.090 |
Why?
|
West Nile Fever | 1 | 2009 | 81 | 0.090 |
Why?
|
Insect Vectors | 1 | 2009 | 134 | 0.080 |
Why?
|
Infant, Newborn | 8 | 2022 | 25628 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3219 | 0.080 |
Why?
|
Uncertainty | 1 | 2013 | 735 | 0.080 |
Why?
|
Incidence | 3 | 2015 | 20950 | 0.080 |
Why?
|
Infant | 5 | 2018 | 35134 | 0.080 |
Why?
|
Urban Population | 1 | 2015 | 2022 | 0.070 |
Why?
|
Child | 6 | 2018 | 77708 | 0.070 |
Why?
|
Child, Preschool | 6 | 2018 | 41005 | 0.070 |
Why?
|
Cleft Lip | 1 | 2012 | 478 | 0.070 |
Why?
|
Cleft Palate | 1 | 2012 | 560 | 0.070 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 814 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1300 | 0.070 |
Why?
|
Software | 1 | 2021 | 4442 | 0.070 |
Why?
|
Demography | 3 | 2009 | 1656 | 0.070 |
Why?
|
Vaccination | 1 | 2018 | 3279 | 0.070 |
Why?
|
Iron | 1 | 2013 | 1774 | 0.060 |
Why?
|
Rural Population | 1 | 2015 | 2207 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2069 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15078 | 0.060 |
Why?
|
Sputum | 2 | 2016 | 476 | 0.060 |
Why?
|
Male | 12 | 2016 | 350118 | 0.060 |
Why?
|
India | 1 | 2010 | 2197 | 0.060 |
Why?
|
Female | 15 | 2022 | 380200 | 0.060 |
Why?
|
Computer Systems | 1 | 2005 | 483 | 0.060 |
Why?
|
Psychomotor Performance | 2 | 2009 | 1901 | 0.060 |
Why?
|
Confidentiality | 1 | 2007 | 612 | 0.060 |
Why?
|
Head | 1 | 2009 | 880 | 0.060 |
Why?
|
Weight Gain | 1 | 2013 | 2293 | 0.050 |
Why?
|
Tuberculosis | 1 | 2015 | 1912 | 0.050 |
Why?
|
Selection Bias | 1 | 2004 | 371 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1714 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2009 | 781 | 0.050 |
Why?
|
Bioterrorism | 1 | 2003 | 143 | 0.050 |
Why?
|
Triplets | 1 | 2002 | 43 | 0.050 |
Why?
|
ROC Curve | 1 | 2010 | 3527 | 0.050 |
Why?
|
Guinea Pigs | 2 | 2015 | 1386 | 0.050 |
Why?
|
Patient Admission | 1 | 2009 | 1380 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3888 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6933 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2002 | 265 | 0.050 |
Why?
|
Chorioamnionitis | 1 | 2002 | 155 | 0.050 |
Why?
|
Leukomalacia, Periventricular | 1 | 2002 | 184 | 0.050 |
Why?
|
Adult | 8 | 2016 | 214056 | 0.050 |
Why?
|
Twins | 1 | 2002 | 339 | 0.050 |
Why?
|
Public Health | 1 | 2013 | 2602 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2002 | 391 | 0.040 |
Why?
|
Malaria | 1 | 2010 | 1239 | 0.040 |
Why?
|
Computational Biology | 2 | 2013 | 3519 | 0.040 |
Why?
|
History, 20th Century | 1 | 2008 | 2740 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2005 | 1254 | 0.040 |
Why?
|
Gestational Age | 1 | 2008 | 3493 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9957 | 0.040 |
Why?
|
Animals | 6 | 2015 | 168770 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25041 | 0.040 |
Why?
|
Adolescent | 4 | 2015 | 85784 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1563 | 0.040 |
Why?
|
Madagascar | 1 | 2018 | 117 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 2 | 2016 | 1877 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4185 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2021 | 63115 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 961 | 0.040 |
Why?
|
Child Development | 1 | 2008 | 2223 | 0.040 |
Why?
|
Massachusetts | 1 | 2009 | 8662 | 0.040 |
Why?
|
Fetal Diseases | 1 | 2002 | 903 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 260 | 0.030 |
Why?
|
Placenta | 2 | 2002 | 1699 | 0.030 |
Why?
|
Hypotension | 1 | 2002 | 884 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4805 | 0.030 |
Why?
|
Genetic Variation | 2 | 2009 | 6542 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2009 | 931 | 0.030 |
Why?
|
Tuberculin Test | 1 | 2015 | 214 | 0.030 |
Why?
|
Uzbekistan | 1 | 2013 | 1 | 0.030 |
Why?
|
Bread | 1 | 2013 | 23 | 0.030 |
Why?
|
Flour | 1 | 2013 | 19 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2016 | 629 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 2 | 2016 | 1832 | 0.030 |
Why?
|
Pregnancy | 4 | 2022 | 29144 | 0.030 |
Why?
|
Folic Acid Deficiency | 1 | 2013 | 115 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2002 | 1332 | 0.030 |
Why?
|
Organization and Administration | 1 | 2012 | 52 | 0.030 |
Why?
|
Food, Fortified | 1 | 2013 | 191 | 0.030 |
Why?
|
Lung Diseases | 1 | 2002 | 1887 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2002 | 2795 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 282 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1677 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1876 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2012 | 373 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9584 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2618 | 0.020 |
Why?
|
Critical Care | 1 | 2003 | 2647 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 610 | 0.020 |
Why?
|
Mozambique | 1 | 2010 | 54 | 0.020 |
Why?
|
Middle Aged | 5 | 2016 | 213388 | 0.020 |
Why?
|
Neutrophils | 1 | 2002 | 3721 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2003 | 3680 | 0.020 |
Why?
|
Insecticide-Treated Bednets | 1 | 2010 | 64 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 72295 | 0.020 |
Why?
|
Private Sector | 1 | 2012 | 392 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 56434 | 0.020 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2012 | 253 | 0.020 |
Why?
|
Peru | 1 | 2012 | 881 | 0.020 |
Why?
|
Certification | 1 | 2012 | 423 | 0.020 |
Why?
|
CD-ROM | 1 | 2008 | 24 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3914 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29786 | 0.020 |
Why?
|
Hemiplegia | 1 | 2008 | 135 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1532 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2012 | 567 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2009 | 802 | 0.020 |
Why?
|
Feces | 1 | 2013 | 1401 | 0.020 |
Why?
|
Risk Assessment | 2 | 2014 | 23336 | 0.020 |
Why?
|
United States | 3 | 2009 | 69869 | 0.020 |
Why?
|
Logistic Models | 1 | 2002 | 13409 | 0.020 |
Why?
|
Quadriplegia | 1 | 2008 | 223 | 0.020 |
Why?
|
Cohort Studies | 3 | 2016 | 40558 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2003 | 5135 | 0.020 |
Why?
|
Benchmarking | 1 | 2012 | 1042 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3587 | 0.020 |
Why?
|
Canada | 1 | 2009 | 2065 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9688 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
Microcephaly | 1 | 2008 | 432 | 0.010 |
Why?
|
Geography | 1 | 2005 | 669 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2971 | 0.010 |
Why?
|
Public Health Administration | 1 | 2005 | 240 | 0.010 |
Why?
|
Cost of Illness | 1 | 2012 | 1860 | 0.010 |
Why?
|
Ureaplasma | 1 | 2002 | 59 | 0.010 |
Why?
|
Infant, Premature | 2 | 2002 | 2045 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19905 | 0.010 |
Why?
|
Bacteria | 1 | 2013 | 2115 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12356 | 0.010 |
Why?
|
Medical History Taking | 1 | 2005 | 784 | 0.010 |
Why?
|
Brain | 2 | 2012 | 26386 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2531 | 0.010 |
Why?
|
Respiration, Artificial | 2 | 2002 | 2569 | 0.010 |
Why?
|
Italy | 1 | 2002 | 832 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 816 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 2003 | 417 | 0.010 |
Why?
|
Motor Activity | 1 | 2009 | 2715 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2002 | 12244 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12952 | 0.010 |
Why?
|
Gastrectomy | 1 | 2002 | 663 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2002 | 976 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8091 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5984 | 0.010 |
Why?
|
DNA | 1 | 2009 | 7294 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2003 | 1410 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 2924 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2005 | 2708 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2003 | 1775 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2008 | 39052 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10636 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10388 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12262 | 0.010 |
Why?
|
Prospective Studies | 2 | 2012 | 53291 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12961 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2012 | 77459 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1917 | 0.010 |
Why?
|
Cognition | 1 | 2008 | 6770 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40077 | 0.010 |
Why?
|
Boston | 1 | 2003 | 9312 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10252 | 0.010 |
Why?
|
Sex Factors | 1 | 2002 | 10400 | 0.000 |
Why?
|
Survival Rate | 1 | 2002 | 12788 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 2002 | 2861 | 0.000 |
Why?
|
Sepsis | 1 | 2002 | 2593 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2005 | 7658 | 0.000 |
Why?
|
Age Factors | 1 | 2002 | 18373 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2002 | 21747 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29060 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35424 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2002 | 57776 | 0.000 |
Why?
|
Aged | 1 | 2002 | 163284 | 0.000 |
Why?
|